Clinical trials
Completed Breast Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
311 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 6 |
| 2002 | 5 |
| 2003 | 19 |
| 2004 | 5 |
| 2005 | 13 |
| 2006 | 14 |
| 2007 | 19 |
| 2008 | 15 |
| 2009 | 25 |
| 2010 | 13 |
| 2011 | 18 |
| 2012 | 16 |
| 2013 | 25 |
| 2014 | 15 |
| 2015 | 12 |
| 2016 | 14 |
| 2017 | 16 |
| 2018 | 17 |
| 2019 | 14 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 9 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 311 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 32 |
| Hoffmann-La Roche | 24 |
| Pfizer | 19 |
| Universitaire Ziekenhuizen KU Leuven | 18 |
| European Organisation for Research and Treatment of Cancer - EORTC | 16 |
| Jules Bordet Institute | 16 |
| AstraZeneca | 13 |
| ETOP IBCSG Partners Foundation | 11 |
| Eli Lilly and Company | 11 |
| University Hospital, Ghent | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 311 |
| Neoplasms | 36 |
| Neoplasm Metastasis | 33 |
| Triple Negative Breast Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Colorectal Neoplasms | 8 |
| Melanoma | 8 |
| Ovarian Neoplasms | 8 |
| Brain Neoplasms | 6 |
| Lung Neoplasms | 6 |
Trials
Showing 1 to 25 of 311. Each trial links to its page on Pharma Observatory.
211 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.